JB Chemicals gets EIR from USFDA for manufacturing facility at Panoli

11 Feb 2020 Evaluate

JB Chemicals & Pharmaceuticals has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the company's newly set up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli in Gujarat. The said inspection was carried out from June 24 to June 28, 2019. At the end of the inspection, ‘No Objectionable Observation’ were found and no Form 483 was issued.

This new facility known as (T20) has already been approved by the other regulatory authorities like EU, TGA-Australia, Saphra-South Africa. This is an another facility in addition to one already approved by USFDA. The new facility will augment the company's manufacturing capacity for regulated markets like USA, EU, Australia and South Africa.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1910.75 -17.65 (-0.92%)
20-Jan-2026 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.00
Dr. Reddys Lab 1165.75
Cipla 1388.00
Zydus Lifesciences 880.25
Lupin 2170.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×